Request information

Organ-on-a-chip metabolomics

Omics

Dr. Thomas Hankemeier works with human in vitro models, known as “organ-on-a-chip”, to help predict clinical treatment outcomes and avoid fatalities.

06 / 22 / 2021 | Thomas Hankemeier

The LACDR team at Leiden University finds biomarkers for cardiovascular, metabolic, and neurological diseases, and then uses them to predict treatment outcomes. Dr. Thomas Hankemeier discusses the importance of using human cell samples to anticipate outcomes that might not be seen in animal models. Accurate mass technologies, crucial for studying their model systems, are highlighted.

  • “And what we found is that this compound, indeed, in animal models, up to the monkey, didn’t show any problems—but in human neurons and in human cell samples, it showed the problem.”

    Thomas Hankemeier

Thomas Hankemeier, PhD

Professor of Analytical BioSciences

Leiden Academic Centre for Drug Research (LACDR)

View profile

Featured products

Click any of the product images to learn more.

  • ZenoTOF 7600 system

    Zeno trap and EAD fragmentation combined in a high-resolution accurate mass system

    Learn more
  • SCIEX Triple Quad 6500+ system

    Revolutionary sensitivity, speed, and performance with IonDrive components

    Learn more
  • QTRAP 6500+ system

    High-throughput mass spectrometry

    Learn more

Related content

Omics
Precision Medicine
SCIEX Now support network
The destination for all your support needs.
Contact support